The use of cannabis as a mood stabilizer in bipolar disorder: Anecdotal evidence and the need for clinical research

被引:0
|
作者
Grinspoon, L [1 ]
Bakalar, JB [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
关键词
bipolar; cannabis; depression; lithium; mania; marijuana;
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The authors present case histories indicating that a number of patients find cannabis (marihuana) useful in the treatment of their bipolar disorder. Some used it to treat mania, depression, or both. They stated that it was more effective than conventional drugs, or helped relieve the side effects of those drugs. One woman found that cannabis curbed her manic rages; she and her husband have worked to make it legally available as a medicine. Others described the use of cannabis as a supplement to lithium (allowing reduced consumption) or for relief of lithium's side effects. Another case illustrates the fact that medical cannabis users are in danger of arrest, especially when children are encouraged to inform on parents by some drug prevention programs. An analogy is drawn between the status of cannabis today and that of lithium in the early 1950s, when its effect on mania had been discovered but there were no controlled studies. In the case of cannabis, the law has made such studies almost impossible, and the only available evidence is anecdotal. The potential for cannabis as a treatment for bipolar disorder unfortunately can not be fully explored in the present social circumstances.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 50 条
  • [21] Clozapine as a mood stabilizer in the treatment of rapid cycling bipolar affective disorder
    Akkaya, C.
    Kilincel, M. O.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S88 - S88
  • [22] Bipolar disorder-mixed episode: adding mood stabilizer to antipsychotics
    Dan, I. A.
    Marian, G.
    Varghes, A.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S251 - S251
  • [23] Cannabis use in first episode bipolar disorder is associated with elevated mood after one year
    Kvitland, L.
    Ringen, P. A.
    Aminoff, S. R.
    Andreassen, O. A.
    Demmo, C.
    Lagerberg, T. V.
    Melle, I. S.
    [J]. BIPOLAR DISORDERS, 2014, 16 : 81 - 81
  • [24] EVIDENCE OF CHAOTIC MOOD VARIATION IN BIPOLAR DISORDER
    GOTTSCHALK, A
    BAUER, MS
    WHYBROW, PC
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1995, 52 (11) : 947 - 959
  • [25] Impulsiveness and disorder of cannabis use in bipolar patients
    Mlika, M.
    Bouallagui, A.
    Moula, O.
    Ferchichi, A.
    Ghachem, R.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S335 - S335
  • [26] Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder
    Braga, Raphael J.
    Burdick, Katherine E.
    DeRosse, Pamela
    Malhotra, Anil K.
    [J]. PSYCHIATRY RESEARCH, 2012, 200 (2-3) : 242 - 245
  • [27] Cannabis and Cannabis Use Disorder: What Nurses Need to Know
    Platter, Bari K.
    [J]. JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2020, 26 (03) : 300 - 300
  • [28] Patterns of cannabis use and clinical correlates among individuals with Major Depressive Disorder and Bipolar Disorder
    Taub, Sharon
    Feingold, Daniel
    Rehm, Juergen
    Lev-Ran, Shaul
    [J]. COMPREHENSIVE PSYCHIATRY, 2018, 80 : 89 - 96
  • [29] Outcome of Mood Stabilizer Discontinuation in Bipolar Disorder After 5 Years of Euthymia
    Sharma, P. S. V. N.
    Kongasseri, Sreejayan
    Praharaj, Samir Kumar
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) : 504 - 507
  • [30] Ziprasidone with adjunctive mood stabilizer in maintenance treatment of bipolar disorder: metabolic profiles
    Karayal, O.
    Ice, K.
    Chappell, P.
    Schwartz, J.
    Siu, C.
    Pappadopulos, E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S462 - S463